Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Excalibur Fund Managers

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 17
Rounds per year 1.00
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.32
Exits 11
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
Summary

Excalibur Fund Managers appeared to be the VC, which was created in 1996. The leading representative office of defined VC is situated in the London. The venture was found in Europe in United Kingdom.

The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Biotechnology, Medical. Among the various public portfolio startups of the fund, we may underline BioVex, Neurotech, Ardana Bioscience

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Excalibur Fund Managers, startups are often financed by Techno Venture Management, Scottish Equity Partners, Avlar BioVentures. The meaningful sponsors for the fund in investment in the same round are 3i Group, Avlar BioVentures, Alice Ventures. In the next rounds fund is usually obtained by Scottish Equity Partners, GeneChem Inc., Avlar BioVentures.

The real fund results show that this VC is 24 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2003. Comparing to the other companies, this Excalibur Fund Managers performs on 15 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2005.

Besides them, we counted 3 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Excalibur Fund Managers:
Typical Co-investors
Excalibur Fund Managers is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Excalibur Fund Managers:
1 CLSA

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amsterdam Venture Partners Amsterdam, Noord-Holland, The Netherlands
Bilibili China, Shanghai
Cap-Meridian Ventures New York, New York, United States
Capital First India, Maharashtra, Mumbai
Deep30 Chiyoda, Japan
Dunamis Ventures Central, Central Region, Singapore
Enterprise Investment Scheme -
Etihad Airways Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Jurisweb Interactiva Barcelona, Catalonia, Spain
NovaVest -
OCA Ventures Chicago, Illinois, United States
Philips Foundation Missouri, Netherlands, United States
SEED Venture Massachusetts, Taunton, United States
Shanghai SIIC Fund Management China, Shanghai
Songshu Touzi Beijing, Beijing, China
Suzanne and Walter Scott Foundation -
Thomas Swan & Co Consett, England, United Kingdom
Xinlan Investment Beijing, Changping, China
Yello Mobile Seoul, Seoul-t'ukpyolsi, South Korea
Zhejiang Xunguang Touzi Guanli Youxian Gongsi China, Zhejiang, Zhoushan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Neurotech

Biotechnology
Medical
Therapeutics
$35M16 Nov 2006 Rhode Island, United States

Onyvax

Biotechnology
Health Care
Therapeutics
$10M08 May 2006 Somerset West and Taunton, England, United Kingdom

Plethora Solutions

Biotechnology
Marketing
Pharmaceutical
01 Jan 2004 United Kingdom, England

Biotechnology
Life Science
Pharmaceutical
$32M30 Jul 2003 United Kingdom, Scotland

Piramed

Biotechnology
Health Care
Medical Device
$13M09 Jul 2003 United Kingdom, England, United Kingdom

Arakis Limited

Biotechnology
Pharmaceutical
$21M26 Apr 2002 London, England, United Kingdom

Biotechnology
Health Care
Medical
$36M20 Feb 2002 United Kingdom, England, United Kingdom

Biotechnology
Life Science
Pharmaceutical
$20M22 Oct 2001 City of Edinburgh, Scotland, United Kingdom

EpiCept Corporation

Information Technology
$13M10 Jan 2001 New Jersey, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Excalibur Fund Managers?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 25
Average round size 13M
Rounds per year 1.00
Peak activity year 2003
Lead investments 9
Follow on index 0.32
Exits 11
Group Appearance index 0.72

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Neurotech

Biotechnology
Medical
Therapeutics
$35M16 Nov 2006 Rhode Island, United States

Onyvax

Biotechnology
Health Care
Therapeutics
$10M08 May 2006 Somerset West and Taunton, England, United Kingdom

Plethora Solutions

Biotechnology
Marketing
Pharmaceutical
01 Jan 2004 United Kingdom, England

Biotechnology
Life Science
Pharmaceutical
$32M30 Jul 2003 United Kingdom, Scotland

Piramed

Biotechnology
Health Care
Medical Device
$13M09 Jul 2003 United Kingdom, England, United Kingdom

Arakis Limited

Biotechnology
Pharmaceutical
$21M26 Apr 2002 London, England, United Kingdom

Biotechnology
Health Care
Medical
$36M20 Feb 2002 United Kingdom, England, United Kingdom

Biotechnology
Life Science
Pharmaceutical
$20M22 Oct 2001 City of Edinburgh, Scotland, United Kingdom

EpiCept Corporation

Information Technology
$13M10 Jan 2001 New Jersey, United States
Crunchbase icon

Content report

The following text will be sent to our editors: